Cell-bound complement activation products in SLE.

about

Cell-bound complement activation products as lupus biomarkers: diagnosis, monitoring and stratification.

P2860

Q47900647-464A5E7A-EB1D-49F6-938F-4102A7CEE919

P2860

Cell-bound complement activation products in SLE.

Item

http://www.wikidata.org/entity/Q46459006

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cell-bound complement activation products in SLE.

@en

Cell-bound complement activation products in SLE.

@nl

type

Item

label

Cell-bound complement activation products in SLE.

@en

Cell-bound complement activation products in SLE.

@nl

prefLabel

Cell-bound complement activation products in SLE.

@en

Cell-bound complement activation products in SLE.

@nl

P1476

Cell-bound complement activation products in SLE.

@en

P2093

Jian Li

http://www.w3.org/2001/XMLSchema#string

Roberta Vezza Alexander

http://www.w3.org/2001/XMLSchema#string

Rosalind Ramsey-Goldman

http://www.w3.org/2001/XMLSchema#string

P2860

Complement in Lupus Nephritis: New Perspectives

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases

Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus

Preclinical systemic lupus erythematosus

The internal thioester and the covalent binding properties of the complement proteins C3 and C4

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.

Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside.

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.

P304

e000236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1136/LUPUS-2017-000236

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Dervieux

P577

2017-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214038

http://www.w3.org/2001/XMLSchema#string

P932

5704741

http://www.w3.org/2001/XMLSchema#string

Cell-bound complement activation products in SLE.

about

P2860

P2860

Cell-bound complement activation products in SLE.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932